Mapping a functional cancer genome atlas of tumor suppressors in mouse liver using AAV-CRISPR-mediated direct in vivo screening.

Sci Adv
Authors
Keywords
Abstract

Cancer genomics consortia have charted the landscapes of numerous human cancers. Whereas some mutations were found in classical oncogenes and tumor suppressors, others have not yet been functionally studied in vivo. To date, a comprehensive assessment of how these genes influence oncogenesis is lacking. We performed direct high-throughput in vivo mapping of functional variants in an autochthonous mouse model of cancer. Using adeno-associated viruses (AAVs) carrying a single-guide RNA (sgRNA) library targeting putative tumor suppressor genes significantly mutated in human cancers, we directly pool-mutagenized the livers of Cre-inducible CRISPR (clustered regularly interspaced short palindromic repeats)-associated protein 9 (Cas9) mice. All mice that received the AAV-mTSG library developed liver cancer and died within 4 months. We used molecular inversion probe sequencing of the sgRNA target sites to chart the mutational landscape of these tumors, revealing the functional consequence of multiple variants in driving liver tumorigenesis in immunocompetent mice. AAV-mediated autochthonous CRISPR screens provide a powerful means for mapping a provisional functional cancer genome atlas of tumor suppressors in vivo.

Year of Publication
2018
Journal
Sci Adv
Volume
4
Issue
2
Pages
eaao5508
Date Published
2018 02
ISSN
2375-2548
DOI
10.1126/sciadv.aao5508
PubMed ID
29503867
PubMed Central ID
PMC5829971
Links
Grant list
R01 CA133404 / CA / NCI NIH HHS / United States
P50 CA121974 / CA / NCI NIH HHS / United States
T32 GM007499 / GM / NIGMS NIH HHS / United States
DP1 HL141201 / HL / NHLBI NIH HHS / United States
HHMI / Howard Hughes Medical Institute / United States
R01 MH110049 / MH / NIMH NIH HHS / United States
T32 GM007205 / GM / NIGMS NIH HHS / United States
U54 CA209992 / CA / NCI NIH HHS / United States
R01 GM034277 / GM / NIGMS NIH HHS / United States
R01 HG009761 / HG / NHGRI NIH HHS / United States
P50 CA196530 / CA / NCI NIH HHS / United States